We are live on ! Find out more
Lord, Abbett & Co

Lord, Abbett & Co Portfolio holdings

AUM $30.6B
1-Year Est. Return 57.44%
This Fund
S&P 500
This Quarter Est. Return
-11.95%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$28.3B
AUM Growth
-$9.23B
Cap. Flow
-$5.59B
Cap. Flow %
-19.76%
Top 10 Hldgs %
17.15%
Holding
651
New
62
Increased
201
Reduced
214
Closed
94

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$97.8M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$95.6M
3
LNG icon
Cheniere Energy
LNG
+$94.4M
4
V icon
Visa
V
+$92.5M
5
AZN icon
AstraZeneca
AZN
+$88.2M

Sector Composition

Rank Sector Weight
1 Technology 20.41%
2 Healthcare 17.34%
3 Financials 13.09%
4 Industrials 10.79%
5 Consumer Discretionary 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.9T
$995M 3.52%
3,874,141
-116,388
-3% -$31.6M
AAPL icon
2
Apple
AAPL
$4.79T
$781M 2.76%
5,714,493
-166,367
-3% -$25.2M
UNH icon
3
UnitedHealth
UNH
$392B
$584M 2.06%
1,136,285
-66,627
-6% -$33.5M
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.17T
$536M 1.9%
4,920,060
-1,660,840
-25% -$196M
RTX icon
5
RTX Corp
RTX
$262B
$388M 1.37%
4,034,187
+343,157
+9% +$33M
ABBV icon
6
AbbVie
ABBV
$448B
$344M 1.22%
2,246,110
-466,822
-17% -$71.3M
ALL icon
7
Allstate
ALL
$64.8B
$330M 1.17%
2,600,794
+544,933
+27% +$71.4M
PFE icon
8
Pfizer
PFE
$141B
$314M 1.11%
5,982,190
-1,389,706
-19% -$70.8M
AMP icon
9
Ameriprise Financial
AMP
$47.4B
$290M 1.02%
1,218,272
-65,607
-5% -$17.6M
OGN icon
10
Organon & Co
OGN
$3.55B
$289M 1.02%
8,576,439
+481,549
+6% +$16.9M
LNG icon
11
Cheniere Energy
LNG
$56B
$287M 1.01%
2,153,964
+693,043
+47% +$94.4M
MS icon
12
Morgan Stanley
MS
$343B
$266M 0.94%
3,495,807
-491,122
-12% -$40.2M
NOC icon
13
Northrop Grumman
NOC
$74.6B
$262M 0.93%
547,084
+5,127
+0.9% +$2.35M
ACN icon
14
Accenture
ACN
$85.7B
$238M 0.84%
856,144
+5,125
+0.6% +$1.54M
LLY icon
15
Eli Lilly
LLY
$1.04T
$237M 0.84%
730,160
+218,147
+43% +$65.5M
SHEL icon
16
Shell
SHEL
$243B
$234M 0.83%
4,476,227
-398,885
-8% -$22.4M
AFG icon
17
American Financial Group
AFG
$11.7B
$231M 0.82%
1,666,846
-385,007
-19% -$54.1M
MA icon
18
Mastercard
MA
$470B
$223M 0.79%
706,169
+170,950
+32% +$58.9M
TSLA icon
19
Tesla
TSLA
$1.4T
$216M 0.76%
960,858
-256,884
-21% -$70.1M
PH icon
20
Parker-Hannifin
PH
$122B
$213M 0.75%
867,291
+129,650
+18% +$34.7M
NEE.PRQ
21
DELISTED
NextEra Energy, Inc. 6.219% Corporate Units
NEE.PRQ
$210M 0.74%
4,276,400
+119,150
+3% +$5.84M
COST icon
22
Costco
COST
$411B
$208M 0.74%
433,935
-71,013
-14% -$36M
KO icon
23
Coca-Cola
KO
$354B
$201M 0.71%
3,194,346
-309,106
-9% -$19.6M
UNP icon
24
Union Pacific
UNP
$174B
$200M 0.71%
936,100
-345,200
-27% -$78.5M
EXE
25
Expand Energy Corp
EXE
$22.3B
$182M 0.64%
2,245,052
-7,193
-0.3% -$650K

Similar funds

Lord, Abbett & Co's Q2 2022 Portfolio in Review

As of Q2 2022, Lord, Abbett & Co held 651 positions worth $28.3B, down 25% from $37.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Lord, Abbett & Co withdrew a net $5.59B in Q2 2022, closing 94 positions and reducing 214 holdings. Its most notable exit was Signature Bank, an estimated $204M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Lord, Abbett & Co opened a new position in Elevance Health worth $95.4M.

  • Lord, Abbett & Co's largest Q2 2022 buy was Elevance Health: 197,668 shares worth $95.4M.
  • Lord, Abbett & Co added most to Seagen Inc. Common Stock in Q2 2022, an estimated $95.6M increase.
  • Lord, Abbett & Co's biggest Q2 2022 reduction was Alphabet (Google) Class A, cutting an estimated $196M.
  • Lord, Abbett & Co fully exited Signature Bank in Q2 2022, selling an estimated $204M.
  • Lord, Abbett & Co's ten largest holdings make up 17% of its $28.3B portfolio in Q2 2022.
  • Lord, Abbett & Co opened 62 new positions and closed 94 in Q2 2022.
  • Lord, Abbett & Co's portfolio value fell 25% quarter-over-quarter to $28.3B.

Based on Lord, Abbett & Co's 13F filing for Q2 2022, filed 12 Aug 2022.